Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Esophagectomy for Cancer
NCT00512265Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pulmonary complications (PPC) comparing N-Acetylcysteine with Placebo (2 arms). Primary endpoints: Inflammatory reaction measured by cytokines at 1 year, Postoperative course of Leucocytes at 1 year and 2 more. Started Jan 2006; status: completed.
02
Drugs
acetylcysteine
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT00512265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512265.